跳至主要内容
临床试验/JPRN-UMIN000023879
JPRN-UMIN000023879已完成未知

Validation study of the recurrence risk stratification using 55-gene classifier (55GC) and RAS mutation in StageII/III colon cancer - Validation study of the recurrence risk stratification using 55-gene classifier (55GC) and RAS mutation in StageII/III colon cancer

ational Defense Medical College and Kyushu University0 个研究点目标入组 1,000 人开始时间: 2016年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 79years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Patients who had received preoperative therapy. (2) Patients with a previous malignancy, within 5 years of operation, except for tumors at the stage of carcinoma in situ. (3) Patients who had recurrence or died within 60 days of surgery.

研究者

发起方
ational Defense Medical College and Kyushu University

相似试验